Immunic Inc logo

Immunic Inc

$ 3.00 -0.21 (-6.54%) 10:08 PM EST
P/E:
At Loss
P/B:
0.72
Market Cap:
$ 91.69M
Enterprise V:
$ 10.81M
Volume:
171.84K
Avg Vol (2M):
120.29K
Also Trade In:
Volume:
171.84K
Market Cap $:
91.69M
PE Ratio:
At Loss
Avg Vol (2-Month):
120.29K
Enterprise Value $:
10.81M
PB Ratio:
0.72
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing three small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.
Name Current Vs Industry Vs History
Cash-To-Debt 113.94
Equity-to-Asset 0.92
Debt-to-Equity 0.01
Debt-to-EBITDA -0.01
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 4.59
9-Day RSI 14.2
14-Day RSI 23.95
6-1 Month Momentum % -60.09
12-1 Month Momentum % -49.13

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 10.07
Quick Ratio 10.07
Cash Ratio 8.47

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -191.9
Name Current Vs Industry Vs History
ROE % -63.1
ROA % -57.73
ROIC % -206.11
ROC (Joel Greenblatt) % -2066.22
ROCE % -62.03

Financials (Next Earnings Date:2022-11-04 Est.)

IMUX's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:IMUX

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Embed

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0
EPS (TTM) ($) -2.82
Beta 1.75
Volatility % 73.84
14-Day RSI 23.95
14-Day ATR ($) 0.336958
20-Day SMA ($) 4.0665
12-1 Month Momentum % -49.13
52-Week Range ($) 2.52 - 14.5
Shares Outstanding (Mil) 30.56

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Immunic Inc Filings

Document Form Filing Date
No Filing Data

Immunic Inc Analysis

Share your research

Headlines

See More
No news.